Blood News and Research

RSS

Compound in saliva and proteins in blood may protect human cells from powerful toxins in tea, coffee

A compound in saliva, along with common proteins in blood and muscle, may protect human cells from powerful toxins in tea, coffee and liquid smoke flavoring, according to results of a new study led by investigators at the Johns Hopkins Kimmel Cancer Center.

31 May 2014

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

On Friday, April 18th PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc.

31 May 2014

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

The tangled highway of blood vessels that twists and turns inside our bodies, delivering essential nutrients and disposing of hazardous waste to keep our organs working properly has been a conundrum for scientists trying to make artificial vessels from scratch.

31 May 2014

Discontinuing statins in patients with advanced illnesses improves quality of life

People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a study presented Friday by researchers at Duke Medicine representing a national research network.

31 May 2014

New research sheds light on brain aneurysm

New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.

30 May 2014

Novozymes Biopharma to assess novel subunit vaccine candidate using Veltis technology

Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis technology, to assess the dosing and performance of a novel subunit antigen vaccine candidate.

30 May 2014

EKF, GILUPI report data on circulating tumour cell DNA enrichment, mutation detection

EKF and GILUPI, announce results from collaborative work using GILUPI CellCollector and EKF Molecular’s PointMan DNA Enrichment technology.

From EKF Diagnostics 30 May 2014

TSRI scientists receive more than $13M to design effective HIV vaccine

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)—which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

California shootings revive debate over involuntary commitment

A bill in the House, which would make it easier for family members and authorities to force people to be treated, is giving some lawmakers pause, while NPR reports how counties in California have been slow to adopt a 2002 state law that gives authorities the ability to mandate outpatient mental health care for people who have been refusing it.

30 May 2014

Signs and symptoms of diabetes

You're approaching 50 and can't help but notice the signs of aging - your vision and hearing aren't what they used to be, and it seems your cuts and bruises take longer to heal.

30 May 2014

Perelman School wins $10M renewal to study oldest part of human immune system

The National Institute of Allergy and Infectious Diseases has awarded the Perelman School of Medicine at the University of Pennsylvania a five-year, $10 million renewal of a program project to study the oldest part of the human immune system called the complement system, or simply "complement."

30 May 2014

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Researchers at the University of Alabama at Birmingham School of Medicine have created an experimental blood test that, for the first time, determines a "Bioenergetic Health Index," or BHI, by gauging the performance of mitochondria, the cell's energy powerhouses.

30 May 2014

Researchers identify new therapeutic target for treating most common form of eye cancer

Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.

30 May 2014

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.

30 May 2014

TSRI scientists receive $13M grant to create effective vaccine against HIV

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)-which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

Vibration exercise may reduce pain in individuals diagnosed with fibromyalgia

A pilot study by Indiana University researchers found that whole-body vibration exercise may reduce pain symptoms and improve aspects of quality of life in individuals diagnosed with fibromyalgia.

30 May 2014

Women with PCOS more likely to experience chronic low-grade inflammation during pregnancy

Women who have polycystic ovary syndrome - the most common hormone disorder in women of reproductive age - are more likely to experience chronic low-grade inflammation during pregnancy than counterparts who do not have the condition, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

30 May 2014

Blood News and Research

Compound in saliva and proteins in blood may protect human cells from powerful toxins in tea, coffee

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

Discontinuing statins in patients with advanced illnesses improves quality of life

New research sheds light on brain aneurysm

Novozymes Biopharma to assess novel subunit vaccine candidate using Veltis technology

EKF, GILUPI report data on circulating tumour cell DNA enrichment, mutation detection

TSRI scientists receive more than $13M to design effective HIV vaccine

California shootings revive debate over involuntary commitment

Signs and symptoms of diabetes

Perelman School wins $10M renewal to study oldest part of human immune system

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Researchers identify new therapeutic target for treating most common form of eye cancer

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

TSRI scientists receive $13M grant to create effective vaccine against HIV

Vibration exercise may reduce pain in individuals diagnosed with fibromyalgia

Women with PCOS more likely to experience chronic low-grade inflammation during pregnancy

Biomedical scientists explore mechanisms of novel treatments for HCV

Study reveals how BTK mutation triggers drug resistance in CLL patients

Innovative device has potential to reduce hemorrhage, save lives

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News